PTPRC and neoplasm: However, previous studies always defined CD45−/DAPI+/CEP8 > 2 as CTCs [13–15], and the circulating tumor endothelial cells (CTECs) aneuploidy was often identified as CTCs because endothelial markers were not exploited.